Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 40 | 2023 | 787 | 7.360 |
Why?
|
Cognition Disorders | 28 | 2016 | 786 | 3.290 |
Why?
|
Brain Injuries, Traumatic | 12 | 2023 | 367 | 2.540 |
Why?
|
Neuropsychiatry | 6 | 2020 | 13 | 2.210 |
Why?
|
Neuropsychological Tests | 30 | 2018 | 1178 | 1.890 |
Why?
|
Mental Disorders | 18 | 2014 | 862 | 1.600 |
Why?
|
Neurosciences | 3 | 2017 | 53 | 1.580 |
Why?
|
Memory Disorders | 7 | 2023 | 295 | 1.410 |
Why?
|
Crying | 6 | 2014 | 14 | 1.210 |
Why?
|
Bipolar Disorder | 9 | 2019 | 376 | 1.120 |
Why?
|
Consciousness Disorders | 5 | 2023 | 34 | 1.120 |
Why?
|
Mood Disorders | 5 | 2014 | 163 | 1.070 |
Why?
|
Affective Symptoms | 5 | 2014 | 102 | 1.050 |
Why?
|
Psychotic Disorders | 5 | 2015 | 147 | 1.020 |
Why?
|
Brain | 21 | 2023 | 4113 | 1.000 |
Why?
|
Laughter | 5 | 2014 | 12 | 1.000 |
Why?
|
Aggression | 4 | 2014 | 252 | 0.970 |
Why?
|
Consciousness | 1 | 2023 | 56 | 0.920 |
Why?
|
Cholinesterase Inhibitors | 4 | 2021 | 110 | 0.910 |
Why?
|
Alcoholism | 6 | 2022 | 285 | 0.900 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2010 | 137 | 0.880 |
Why?
|
Receptors, Cholinergic | 4 | 2011 | 84 | 0.870 |
Why?
|
Evoked Potentials, Auditory | 6 | 2004 | 50 | 0.860 |
Why?
|
Lupus Erythematosus, Systemic | 8 | 2013 | 223 | 0.860 |
Why?
|
Nervous System Diseases | 7 | 2020 | 500 | 0.800 |
Why?
|
Forensic Psychiatry | 2 | 2013 | 12 | 0.790 |
Why?
|
Irritable Mood | 3 | 2022 | 12 | 0.750 |
Why?
|
Brain Concussion | 5 | 2023 | 194 | 0.750 |
Why?
|
Psychomotor Performance | 5 | 2011 | 233 | 0.750 |
Why?
|
Psychiatry | 4 | 2016 | 307 | 0.710 |
Why?
|
Functional Laterality | 8 | 2016 | 316 | 0.690 |
Why?
|
Acetylcholine | 4 | 2011 | 96 | 0.690 |
Why?
|
Hallucinations | 2 | 2016 | 35 | 0.680 |
Why?
|
Amnesia | 3 | 2023 | 32 | 0.670 |
Why?
|
Hippocampus | 9 | 2019 | 915 | 0.660 |
Why?
|
Cognition | 7 | 2018 | 968 | 0.660 |
Why?
|
Brain Injury, Chronic | 2 | 2013 | 21 | 0.650 |
Why?
|
Confusion | 2 | 2020 | 31 | 0.630 |
Why?
|
Attention | 9 | 2019 | 281 | 0.630 |
Why?
|
Cholinergic Fibers | 3 | 2011 | 11 | 0.630 |
Why?
|
Memory | 6 | 2017 | 429 | 0.610 |
Why?
|
Aphasia | 2 | 2015 | 21 | 0.610 |
Why?
|
Antipsychotic Agents | 4 | 2015 | 414 | 0.610 |
Why?
|
Humans | 120 | 2023 | 261506 | 0.590 |
Why?
|
Neurology | 2 | 2010 | 113 | 0.580 |
Why?
|
Capgras Syndrome | 1 | 2016 | 3 | 0.560 |
Why?
|
Politics | 1 | 2017 | 74 | 0.560 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2014 | 231 | 0.550 |
Why?
|
Impulsive Behavior | 2 | 2014 | 142 | 0.550 |
Why?
|
Pseudobulbar Palsy | 2 | 2005 | 4 | 0.530 |
Why?
|
Dopamine Agents | 2 | 2006 | 38 | 0.530 |
Why?
|
Dementia | 3 | 2013 | 453 | 0.530 |
Why?
|
Stroke Rehabilitation | 2 | 2005 | 61 | 0.510 |
Why?
|
Journalism, Medical | 1 | 2015 | 11 | 0.510 |
Why?
|
Expert Testimony | 2 | 2013 | 90 | 0.510 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2015 | 41 | 0.500 |
Why?
|
West Nile Fever | 2 | 2008 | 151 | 0.480 |
Why?
|
Recovery of Function | 5 | 2019 | 703 | 0.480 |
Why?
|
Severity of Illness Index | 12 | 2011 | 4320 | 0.480 |
Why?
|
Diagnosis, Differential | 16 | 2017 | 4744 | 0.480 |
Why?
|
Connectome | 3 | 2023 | 112 | 0.480 |
Why?
|
Football | 1 | 2013 | 37 | 0.460 |
Why?
|
Mental Status Schedule | 2 | 2010 | 60 | 0.440 |
Why?
|
Behavioral Symptoms | 1 | 2013 | 32 | 0.440 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 133 | 0.440 |
Why?
|
Indans | 1 | 2013 | 68 | 0.430 |
Why?
|
Neurotransmitter Agents | 3 | 2008 | 159 | 0.430 |
Why?
|
Schizophrenia | 4 | 2015 | 369 | 0.420 |
Why?
|
Violence | 1 | 2013 | 116 | 0.420 |
Why?
|
Post-Concussion Syndrome | 3 | 2013 | 53 | 0.410 |
Why?
|
Phenylcarbamates | 2 | 2009 | 25 | 0.410 |
Why?
|
Veterans | 4 | 2023 | 1641 | 0.400 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2015 | 901 | 0.400 |
Why?
|
Periodicals as Topic | 1 | 2016 | 338 | 0.400 |
Why?
|
Electroencephalography | 4 | 2015 | 898 | 0.390 |
Why?
|
Adult | 47 | 2021 | 77950 | 0.390 |
Why?
|
Indians, North American | 2 | 2010 | 87 | 0.380 |
Why?
|
Suicide | 1 | 2013 | 180 | 0.370 |
Why?
|
Military Personnel | 2 | 2023 | 225 | 0.370 |
Why?
|
Male | 61 | 2021 | 123000 | 0.370 |
Why?
|
Capital Punishment | 1 | 2010 | 3 | 0.370 |
Why?
|
Surveys and Questionnaires | 5 | 2023 | 5687 | 0.370 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 441 | 0.360 |
Why?
|
Neuroprotective Agents | 2 | 2009 | 215 | 0.350 |
Why?
|
Public Policy | 1 | 2010 | 60 | 0.350 |
Why?
|
Injury Severity Score | 5 | 2019 | 237 | 0.340 |
Why?
|
Cerebral Cortex | 5 | 2019 | 621 | 0.330 |
Why?
|
Reflex | 1 | 2009 | 68 | 0.330 |
Why?
|
Diffusion Tensor Imaging | 1 | 2011 | 303 | 0.330 |
Why?
|
Amygdala | 3 | 2018 | 127 | 0.320 |
Why?
|
Insanity Defense | 1 | 2008 | 2 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 305 | 0.320 |
Why?
|
Neuroanatomy | 2 | 2023 | 14 | 0.320 |
Why?
|
Geriatric Assessment | 1 | 2010 | 275 | 0.320 |
Why?
|
Dibenzothiazepines | 1 | 2007 | 13 | 0.320 |
Why?
|
Physical Therapy Modalities | 2 | 2005 | 95 | 0.310 |
Why?
|
Crime | 1 | 2008 | 31 | 0.310 |
Why?
|
Affect | 4 | 2008 | 288 | 0.310 |
Why?
|
Central Nervous System Stimulants | 4 | 2016 | 225 | 0.300 |
Why?
|
Rivastigmine | 3 | 2021 | 26 | 0.300 |
Why?
|
Piperidines | 1 | 2013 | 1035 | 0.300 |
Why?
|
Stroke | 5 | 2015 | 1144 | 0.300 |
Why?
|
Magnetic Resonance Imaging | 18 | 2019 | 7702 | 0.290 |
Why?
|
Depression | 4 | 2009 | 1715 | 0.280 |
Why?
|
Behavioral Sciences | 1 | 2006 | 10 | 0.280 |
Why?
|
Hiccup | 1 | 2006 | 17 | 0.280 |
Why?
|
Adrenergic Agents | 1 | 2006 | 18 | 0.280 |
Why?
|
Middle Aged | 37 | 2021 | 86204 | 0.270 |
Why?
|
Delirium | 1 | 2008 | 207 | 0.270 |
Why?
|
Neuropsychology | 1 | 2006 | 33 | 0.270 |
Why?
|
Alzheimer Disease | 3 | 2011 | 855 | 0.270 |
Why?
|
Hemiplegia | 1 | 2005 | 47 | 0.270 |
Why?
|
Methylphenidate | 3 | 2016 | 103 | 0.260 |
Why?
|
Double-Blind Method | 5 | 2022 | 2588 | 0.260 |
Why?
|
Paresis | 1 | 2005 | 54 | 0.260 |
Why?
|
Amantadine | 1 | 2004 | 33 | 0.260 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2021 | 604 | 0.260 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2004 | 9 | 0.250 |
Why?
|
Motor Skills | 1 | 2005 | 107 | 0.250 |
Why?
|
Upper Extremity | 1 | 2005 | 87 | 0.250 |
Why?
|
Specialization | 1 | 2006 | 130 | 0.250 |
Why?
|
Disability Evaluation | 3 | 2019 | 249 | 0.250 |
Why?
|
Psychosurgery | 1 | 2004 | 28 | 0.250 |
Why?
|
Female | 46 | 2021 | 141928 | 0.250 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 792 | 0.250 |
Why?
|
Neurologic Examination | 5 | 2008 | 245 | 0.250 |
Why?
|
Neuroimaging | 5 | 2019 | 403 | 0.220 |
Why?
|
Hospital Mortality | 1 | 2008 | 1274 | 0.220 |
Why?
|
Emotions | 3 | 2019 | 562 | 0.220 |
Why?
|
Exercise Therapy | 1 | 2005 | 288 | 0.210 |
Why?
|
Critical Care | 1 | 2008 | 770 | 0.210 |
Why?
|
Magnetoencephalography | 5 | 2011 | 37 | 0.210 |
Why?
|
Delusions | 2 | 2015 | 21 | 0.210 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 524 | 0.210 |
Why?
|
Comorbidity | 3 | 2014 | 2352 | 0.210 |
Why?
|
Prisoners | 1 | 2021 | 34 | 0.200 |
Why?
|
Valproic Acid | 2 | 2022 | 263 | 0.200 |
Why?
|
Treatment Outcome | 13 | 2022 | 32848 | 0.200 |
Why?
|
Thalamus | 2 | 2018 | 132 | 0.200 |
Why?
|
Research Design | 1 | 2009 | 1544 | 0.200 |
Why?
|
Dominance, Cerebral | 1 | 2000 | 81 | 0.190 |
Why?
|
Analysis of Variance | 5 | 2007 | 2307 | 0.190 |
Why?
|
Central Nervous System Agents | 1 | 2000 | 20 | 0.190 |
Why?
|
Mental Status and Dementia Tests | 1 | 2020 | 36 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 3719 | 0.190 |
Why?
|
Regression Analysis | 5 | 2013 | 1546 | 0.180 |
Why?
|
Conversion Disorder | 1 | 2020 | 10 | 0.180 |
Why?
|
Electroconvulsive Therapy | 2 | 2014 | 59 | 0.180 |
Why?
|
Acceptance and Commitment Therapy | 1 | 2020 | 40 | 0.180 |
Why?
|
Rehabilitation Centers | 1 | 2020 | 83 | 0.180 |
Why?
|
Chronic Traumatic Encephalopathy | 1 | 2019 | 8 | 0.170 |
Why?
|
Physical and Rehabilitation Medicine | 1 | 2020 | 46 | 0.170 |
Why?
|
Glasgow Coma Scale | 2 | 2011 | 215 | 0.170 |
Why?
|
Hospitalization | 1 | 2008 | 2083 | 0.170 |
Why?
|
Adult Survivors of Child Adverse Events | 1 | 2019 | 20 | 0.170 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 4892 | 0.170 |
Why?
|
Facial Expression | 1 | 2019 | 49 | 0.170 |
Why?
|
Sensory Thresholds | 1 | 1999 | 68 | 0.170 |
Why?
|
Biomechanical Phenomena | 2 | 2011 | 338 | 0.160 |
Why?
|
Lithium Compounds | 1 | 2018 | 15 | 0.160 |
Why?
|
Habenula | 1 | 2018 | 44 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2013 | 624 | 0.150 |
Why?
|
Spatial Memory | 1 | 2017 | 41 | 0.150 |
Why?
|
Sertraline | 2 | 2009 | 45 | 0.150 |
Why?
|
Choline | 4 | 2013 | 76 | 0.150 |
Why?
|
Suicide, Attempted | 1 | 2018 | 129 | 0.150 |
Why?
|
Brain Diseases | 1 | 2000 | 403 | 0.150 |
Why?
|
Glutamic Acid | 2 | 2011 | 309 | 0.140 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 356 | 0.140 |
Why?
|
Encephalitis | 1 | 2017 | 143 | 0.140 |
Why?
|
Cognitive Dysfunction | 1 | 2021 | 333 | 0.140 |
Why?
|
Suicidal Ideation | 1 | 2018 | 207 | 0.140 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 88 | 0.130 |
Why?
|
Aspartic Acid | 3 | 2011 | 126 | 0.130 |
Why?
|
Prospective Studies | 6 | 2017 | 12873 | 0.130 |
Why?
|
Frontal Lobe | 3 | 2013 | 187 | 0.130 |
Why?
|
Range of Motion, Articular | 2 | 2005 | 144 | 0.120 |
Why?
|
Anxiety Disorders | 2 | 2014 | 666 | 0.120 |
Why?
|
Behavior, Animal | 1 | 2017 | 709 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 1085 | 0.120 |
Why?
|
Creatine | 2 | 2011 | 61 | 0.120 |
Why?
|
Executive Function | 2 | 2016 | 160 | 0.120 |
Why?
|
Reproducibility of Results | 4 | 2019 | 6009 | 0.120 |
Why?
|
Volition | 2 | 2006 | 11 | 0.110 |
Why?
|
Aged | 13 | 2019 | 70117 | 0.110 |
Why?
|
Leukoencephalopathies | 1 | 2013 | 63 | 0.110 |
Why?
|
Frontotemporal Dementia | 1 | 2013 | 40 | 0.110 |
Why?
|
Multiple Sclerosis | 2 | 2007 | 349 | 0.110 |
Why?
|
Terminology as Topic | 2 | 2008 | 414 | 0.110 |
Why?
|
White Matter | 1 | 2015 | 195 | 0.110 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 341 | 0.110 |
Why?
|
Length of Stay | 2 | 2011 | 1900 | 0.110 |
Why?
|
Blast Injuries | 1 | 2012 | 48 | 0.100 |
Why?
|
Hyperbaric Oxygenation | 1 | 2012 | 48 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2011 | 6100 | 0.100 |
Why?
|
Forensic Medicine | 1 | 2011 | 16 | 0.100 |
Why?
|
Delphi Technique | 2 | 2023 | 210 | 0.100 |
Why?
|
Neurobiology | 1 | 2011 | 25 | 0.100 |
Why?
|
Rest | 1 | 2011 | 71 | 0.100 |
Why?
|
Trauma Severity Indices | 1 | 2011 | 98 | 0.100 |
Why?
|
Inpatients | 2 | 2018 | 678 | 0.090 |
Why?
|
Anxiety | 1 | 2017 | 1179 | 0.090 |
Why?
|
Economics | 1 | 2010 | 11 | 0.090 |
Why?
|
Supreme Court Decisions | 1 | 2010 | 12 | 0.090 |
Why?
|
Schizophrenic Psychology | 2 | 2002 | 102 | 0.090 |
Why?
|
Language Disorders | 1 | 2010 | 26 | 0.090 |
Why?
|
United States | 6 | 2023 | 15433 | 0.090 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 1999 | 60 | 0.090 |
Why?
|
Antidepressive Agents | 2 | 2018 | 332 | 0.090 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 35 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2010 | 83 | 0.090 |
Why?
|
Citalopram | 1 | 2009 | 36 | 0.090 |
Why?
|
Capsules | 1 | 2009 | 53 | 0.090 |
Why?
|
Atrophy | 2 | 2007 | 261 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2014 | 748 | 0.080 |
Why?
|
Time | 1 | 2009 | 178 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2011 | 29902 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2010 | 290 | 0.080 |
Why?
|
Neurochemistry | 1 | 2008 | 6 | 0.080 |
Why?
|
Cohort Studies | 4 | 2023 | 9244 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2010 | 156 | 0.080 |
Why?
|
Research | 1 | 2011 | 415 | 0.080 |
Why?
|
Dissociative Disorders | 1 | 2008 | 10 | 0.080 |
Why?
|
Autoantibodies | 1 | 2011 | 576 | 0.080 |
Why?
|
Quetiapine Fumarate | 1 | 2007 | 16 | 0.080 |
Why?
|
Presenilin-2 | 1 | 2007 | 20 | 0.080 |
Why?
|
Motor Activity | 2 | 2017 | 693 | 0.080 |
Why?
|
Consensus | 2 | 2023 | 978 | 0.080 |
Why?
|
Presenilin-1 | 1 | 2007 | 71 | 0.080 |
Why?
|
Phenotype | 1 | 1999 | 6295 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 259 | 0.080 |
Why?
|
Wasting Disease, Chronic | 1 | 2007 | 1 | 0.080 |
Why?
|
Receptors, Neurotransmitter | 1 | 2007 | 27 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2019 | 37905 | 0.080 |
Why?
|
Risk Assessment | 3 | 2011 | 6869 | 0.070 |
Why?
|
Medical Records | 1 | 2009 | 415 | 0.070 |
Why?
|
Adolescent | 6 | 2019 | 31252 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2007 | 116 | 0.070 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2006 | 14 | 0.070 |
Why?
|
Intelligence Tests | 1 | 2007 | 88 | 0.070 |
Why?
|
Antibodies | 1 | 2010 | 838 | 0.070 |
Why?
|
Neurosecretory Systems | 1 | 2007 | 66 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 3260 | 0.070 |
Why?
|
Prognosis | 4 | 2019 | 21713 | 0.070 |
Why?
|
Expressed Emotion | 1 | 2006 | 22 | 0.070 |
Why?
|
Biogenic Amines | 1 | 2006 | 15 | 0.070 |
Why?
|
Lithium Carbonate | 1 | 2006 | 21 | 0.070 |
Why?
|
Illusions | 1 | 2006 | 10 | 0.070 |
Why?
|
Sex Factors | 2 | 2003 | 2139 | 0.070 |
Why?
|
Animals | 7 | 2017 | 59536 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2023 | 1945 | 0.070 |
Why?
|
Education | 1 | 2006 | 112 | 0.070 |
Why?
|
Health Surveys | 1 | 2007 | 402 | 0.070 |
Why?
|
Demography | 1 | 2007 | 435 | 0.070 |
Why?
|
Medical History Taking | 1 | 2006 | 173 | 0.070 |
Why?
|
Young Adult | 5 | 2019 | 21445 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2006 | 388 | 0.060 |
Why?
|
Diazepam | 1 | 2004 | 39 | 0.060 |
Why?
|
Restraint, Physical | 1 | 2005 | 50 | 0.060 |
Why?
|
Disease Management | 1 | 2010 | 1052 | 0.060 |
Why?
|
History, Ancient | 1 | 2004 | 68 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2004 | 77 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2006 | 170 | 0.060 |
Why?
|
Colorado | 3 | 2011 | 28 | 0.060 |
Why?
|
Psychological Tests | 1 | 2005 | 131 | 0.060 |
Why?
|
Physostigmine | 1 | 2004 | 8 | 0.060 |
Why?
|
Arm | 1 | 2005 | 147 | 0.060 |
Why?
|
Narcotics | 1 | 2004 | 123 | 0.060 |
Why?
|
History, 19th Century | 1 | 2004 | 154 | 0.060 |
Why?
|
Nerve Net | 1 | 2007 | 257 | 0.060 |
Why?
|
Cooperative Behavior | 2 | 2006 | 313 | 0.060 |
Why?
|
North America | 1 | 2004 | 314 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2005 | 756 | 0.060 |
Why?
|
Age of Onset | 1 | 2006 | 827 | 0.060 |
Why?
|
Probability | 1 | 2005 | 866 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2010 | 899 | 0.060 |
Why?
|
Incidence | 2 | 2011 | 5673 | 0.060 |
Why?
|
Akinetic Mutism | 1 | 2003 | 1 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2005 | 497 | 0.060 |
Why?
|
Cerebral Arterial Diseases | 1 | 2003 | 6 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 5377 | 0.060 |
Why?
|
Methadone | 1 | 2004 | 195 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 2004 | 218 | 0.060 |
Why?
|
Electrophysiology | 1 | 2003 | 333 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 3472 | 0.050 |
Why?
|
Datasets as Topic | 1 | 2023 | 181 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 4971 | 0.050 |
Why?
|
Cytokines | 1 | 2011 | 2809 | 0.050 |
Why?
|
Geriatric Psychiatry | 1 | 2002 | 17 | 0.050 |
Why?
|
Physician's Role | 1 | 2004 | 238 | 0.050 |
Why?
|
Chronic Disease | 2 | 2005 | 1819 | 0.050 |
Why?
|
History, 20th Century | 1 | 2004 | 574 | 0.050 |
Why?
|
Disease Progression | 2 | 2011 | 6682 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2006 | 390 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2002 | 38 | 0.050 |
Why?
|
Health Services for the Aged | 1 | 2002 | 50 | 0.050 |
Why?
|
Inflammation | 1 | 2011 | 2522 | 0.050 |
Why?
|
Unconsciousness | 1 | 2001 | 21 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2021 | 9 | 0.050 |
Why?
|
Prefrontal Cortex | 1 | 2023 | 229 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2005 | 431 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2005 | 557 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 7551 | 0.050 |
Why?
|
Psychotherapy | 1 | 2003 | 247 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2005 | 554 | 0.050 |
Why?
|
Patient Selection | 1 | 2009 | 2055 | 0.050 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2000 | 5 | 0.050 |
Why?
|
Psychomotor Disorders | 1 | 2000 | 32 | 0.050 |
Why?
|
Rehabilitation Research | 1 | 2020 | 3 | 0.050 |
Why?
|
Time Factors | 2 | 2007 | 12926 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2005 | 509 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2000 | 104 | 0.050 |
Why?
|
Curriculum | 1 | 2006 | 860 | 0.050 |
Why?
|
Epilepsies, Partial | 1 | 2000 | 111 | 0.040 |
Why?
|
Social Stigma | 1 | 2020 | 73 | 0.040 |
Why?
|
Happiness | 1 | 2019 | 11 | 0.040 |
Why?
|
Acute Disease | 1 | 2004 | 2422 | 0.040 |
Why?
|
Magnetics | 1 | 1999 | 107 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2019 | 47 | 0.040 |
Why?
|
Pituitary Gland | 1 | 1999 | 150 | 0.040 |
Why?
|
Reaction Time | 1 | 2000 | 234 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2000 | 209 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 708 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2020 | 245 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2019 | 190 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2011 | 7222 | 0.040 |
Why?
|
Societies, Medical | 2 | 2020 | 1335 | 0.040 |
Why?
|
Gliosis | 1 | 2017 | 41 | 0.040 |
Why?
|
Gray Matter | 1 | 2018 | 63 | 0.040 |
Why?
|
Reference Values | 1 | 2000 | 1099 | 0.040 |
Why?
|
Treatment Failure | 1 | 2021 | 1391 | 0.040 |
Why?
|
Fear | 1 | 2019 | 254 | 0.040 |
Why?
|
Maze Learning | 1 | 2017 | 132 | 0.040 |
Why?
|
Organ Size | 1 | 2019 | 690 | 0.040 |
Why?
|
Temporal Lobe | 1 | 2019 | 192 | 0.040 |
Why?
|
Syndrome | 1 | 2000 | 1351 | 0.040 |
Why?
|
Brain Chemistry | 2 | 2009 | 145 | 0.040 |
Why?
|
Mass Screening | 1 | 2005 | 1509 | 0.040 |
Why?
|
Microglia | 1 | 2017 | 164 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2004 | 1011 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2015 | 111 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1999 | 592 | 0.030 |
Why?
|
Models, Animal | 1 | 2017 | 664 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2019 | 1021 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2010 | 672 | 0.030 |
Why?
|
Astrocytes | 1 | 2017 | 368 | 0.030 |
Why?
|
Biomarkers | 2 | 2011 | 5047 | 0.030 |
Why?
|
Caregivers | 1 | 2020 | 677 | 0.030 |
Why?
|
Linear Models | 1 | 2016 | 1085 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2018 | 14889 | 0.030 |
Why?
|
Child | 2 | 2019 | 29154 | 0.030 |
Why?
|
Software | 1 | 1999 | 1321 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2013 | 160 | 0.030 |
Why?
|
Creatinine | 1 | 2013 | 531 | 0.020 |
Why?
|
Pilot Projects | 2 | 2010 | 2803 | 0.020 |
Why?
|
Visual Perception | 1 | 2011 | 154 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8865 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2011 | 4298 | 0.020 |
Why?
|
Risk Factors | 2 | 2004 | 17523 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 4758 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 1323 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2004 | 5542 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 4314 | 0.020 |
Why?
|
Neurofibrillary Tangles | 1 | 2007 | 24 | 0.020 |
Why?
|
Mental Health Services | 1 | 2010 | 227 | 0.020 |
Why?
|
Pituitary Hormones, Anterior | 1 | 2007 | 4 | 0.020 |
Why?
|
Disease Reservoirs | 1 | 2007 | 42 | 0.020 |
Why?
|
Pituitary Gland, Anterior | 1 | 2007 | 30 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2007 | 104 | 0.020 |
Why?
|
Brain Mapping | 1 | 2011 | 644 | 0.020 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2007 | 17 | 0.020 |
Why?
|
Thyrotropin | 1 | 2007 | 119 | 0.020 |
Why?
|
Prolactin | 1 | 2007 | 155 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 2173 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2007 | 156 | 0.020 |
Why?
|
Stereotyping | 1 | 2006 | 23 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2007 | 78 | 0.020 |
Why?
|
Introns | 1 | 2007 | 432 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2007 | 327 | 0.020 |
Why?
|
Axons | 1 | 2009 | 403 | 0.020 |
Why?
|
Mental Processes | 1 | 2005 | 53 | 0.020 |
Why?
|
Saliva | 1 | 2006 | 231 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2005 | 62 | 0.020 |
Why?
|
Carbamazepine | 1 | 2005 | 49 | 0.020 |
Why?
|
Antiemetics | 1 | 2006 | 125 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2007 | 829 | 0.020 |
Why?
|
MEDLINE | 1 | 2005 | 36 | 0.020 |
Why?
|
Skull | 1 | 2006 | 231 | 0.020 |
Why?
|
Vomiting | 1 | 2006 | 354 | 0.020 |
Why?
|
Point Mutation | 1 | 2007 | 769 | 0.020 |
Why?
|
Central Nervous System Diseases | 1 | 2005 | 129 | 0.020 |
Why?
|
Language | 1 | 2005 | 309 | 0.010 |
Why?
|
Central Nervous System | 1 | 2005 | 436 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2005 | 292 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 1450 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2004 | 397 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2003 | 140 | 0.010 |
Why?
|
Benzamides | 1 | 2006 | 1832 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 1904 | 0.010 |
Why?
|
Median Nerve | 1 | 1999 | 24 | 0.010 |
Why?
|
Pain | 1 | 2007 | 1658 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 4938 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1999 | 426 | 0.010 |
Why?
|
Mice | 1 | 2017 | 34495 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 544 | 0.010 |
Why?
|